vs
Side-by-side financial comparison of LXP Industrial Trust (LXP) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $86.7M, roughly 1.9× LXP Industrial Trust). LXP Industrial Trust runs the higher net margin — 33.2% vs -82.0%, a 115.1% gap on every dollar of revenue. On growth, LXP Industrial Trust posted the faster year-over-year revenue change (-14.0% vs -22.7%). Over the past eight quarters, LXP Industrial Trust's revenue compounded faster (0.3% CAGR vs -11.5%).
LXP Industrial Trust is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality industrial real estate assets, primarily distribution centers, logistics facilities, and light industrial properties across key markets in the United States. Its tenant base covers e-commerce, third-party logistics, and advanced manufacturing sectors, delivering stable long-term returns for its investors.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
LXP vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $86.7M | $164.7M |
| Net Profit | $28.8M | $-135.0M |
| Gross Margin | 81.5% | — |
| Operating Margin | 34.6% | -43.3% |
| Net Margin | 33.2% | -82.0% |
| Revenue YoY | -14.0% | -22.7% |
| Net Profit YoY | — | -104.8% |
| EPS (diluted) | — | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $86.7M | $164.7M | ||
| Q3 25 | $86.9M | $211.0M | ||
| Q2 25 | $87.7M | $178.9M | ||
| Q1 25 | $88.9M | $1.2B | ||
| Q4 24 | $100.9M | $213.2M | ||
| Q3 24 | $85.6M | $196.8M | ||
| Q2 24 | $85.8M | $186.7M | ||
| Q1 24 | $86.3M | $210.1M |
| Q4 25 | $28.8M | $-135.0M | ||
| Q3 25 | $36.3M | $15.9M | ||
| Q2 25 | $29.1M | $-64.8M | ||
| Q1 25 | $19.0M | $866.6M | ||
| Q4 24 | — | $-65.9M | ||
| Q3 24 | $6.3M | $-106.7M | ||
| Q2 24 | $5.4M | $-99.2M | ||
| Q1 24 | $-269.0K | $-91.6M |
| Q4 25 | 81.5% | — | ||
| Q3 25 | 82.3% | — | ||
| Q2 25 | 81.9% | — | ||
| Q1 25 | 80.7% | — | ||
| Q4 24 | 85.3% | — | ||
| Q3 24 | 82.5% | — | ||
| Q2 24 | 82.0% | — | ||
| Q1 24 | 82.4% | — |
| Q4 25 | 34.6% | -43.3% | ||
| Q3 25 | 50.4% | 1.4% | ||
| Q2 25 | 33.7% | -19.5% | ||
| Q1 25 | 21.8% | 82.5% | ||
| Q4 24 | — | -76.2% | ||
| Q3 24 | 7.9% | -27.7% | ||
| Q2 24 | 6.9% | -21.5% | ||
| Q1 24 | 1.0% | -21.6% |
| Q4 25 | 33.2% | -82.0% | ||
| Q3 25 | 41.7% | 7.5% | ||
| Q2 25 | 33.2% | -36.3% | ||
| Q1 25 | 21.4% | 73.7% | ||
| Q4 24 | — | -30.9% | ||
| Q3 24 | 7.4% | -54.2% | ||
| Q2 24 | 6.3% | -53.1% | ||
| Q1 24 | -0.3% | -43.6% |
| Q4 25 | — | $-1.63 | ||
| Q3 25 | $0.12 | $0.20 | ||
| Q2 25 | $0.09 | $-0.83 | ||
| Q1 25 | $0.06 | $10.04 | ||
| Q4 24 | — | $-0.85 | ||
| Q3 24 | $0.02 | $-1.39 | ||
| Q2 24 | $0.01 | $-1.29 | ||
| Q1 24 | $-0.01 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $170.4M | $1.9B |
| Total DebtLower is stronger | $1.4B | — |
| Stockholders' EquityBook value | $2.0B | $-205.3M |
| Total Assets | $3.5B | $2.9B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $170.4M | $1.9B | ||
| Q3 25 | $229.7M | $1.7B | ||
| Q2 25 | $71.0M | $2.0B | ||
| Q1 25 | $70.9M | $2.0B | ||
| Q4 24 | $101.8M | $1.1B | ||
| Q3 24 | $55.0M | $1.0B | ||
| Q2 24 | $48.7M | $1.1B | ||
| Q1 24 | $293.8M | $884.8M |
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $2.0B | $-205.3M | ||
| Q3 25 | $2.1B | $-155.8M | ||
| Q2 25 | $2.1B | $-206.5M | ||
| Q1 25 | $2.1B | $-185.8M | ||
| Q4 24 | $2.1B | $-1.1B | ||
| Q3 24 | $2.1B | $-1.1B | ||
| Q2 24 | $2.1B | $-980.2M | ||
| Q1 24 | $2.2B | $-893.9M |
| Q4 25 | $3.5B | $2.9B | ||
| Q3 25 | $3.7B | $2.6B | ||
| Q2 25 | $3.7B | $2.6B | ||
| Q1 25 | $3.8B | $2.7B | ||
| Q4 24 | $3.8B | $1.7B | ||
| Q3 24 | $3.9B | $1.8B | ||
| Q2 24 | $3.9B | $1.9B | ||
| Q1 24 | $4.2B | $1.8B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.72× | — | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 0.73× | — | ||
| Q4 24 | 0.75× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $188.7M | $-34.3M |
| Free Cash FlowOCF − Capex | — | $-36.6M |
| FCF MarginFCF / Revenue | — | -22.3% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | 6.56× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $188.7M | $-34.3M | ||
| Q3 25 | $63.5M | $-66.3M | ||
| Q2 25 | $44.3M | $-58.3M | ||
| Q1 25 | $39.0M | $870.1M | ||
| Q4 24 | $211.2M | $-30.0M | ||
| Q3 24 | $64.6M | $-77.0M | ||
| Q2 24 | $38.5M | $-71.5M | ||
| Q1 24 | $38.9M | $70.8M |
| Q4 25 | — | $-36.6M | ||
| Q3 25 | — | $-69.7M | ||
| Q2 25 | — | $-59.6M | ||
| Q1 25 | — | $868.4M | ||
| Q4 24 | — | $-33.8M | ||
| Q3 24 | — | $-77.5M | ||
| Q2 24 | — | $-78.8M | ||
| Q1 24 | — | $61.2M |
| Q4 25 | — | -22.3% | ||
| Q3 25 | — | -33.1% | ||
| Q2 25 | — | -33.3% | ||
| Q1 25 | — | 73.8% | ||
| Q4 24 | — | -15.8% | ||
| Q3 24 | — | -39.4% | ||
| Q2 24 | — | -42.2% | ||
| Q1 24 | — | 29.1% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 4.0% | ||
| Q1 24 | — | 4.6% |
| Q4 25 | 6.56× | — | ||
| Q3 25 | 1.75× | -4.17× | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | 2.05× | 1.00× | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.18× | — | ||
| Q2 24 | 7.09× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
